carbapenem-resistant

For example, Carbapenem-resistant bacteria are 20 times as common in India as they are in the U.

For a good time, take a look at carbapenem-resistant enterobacteriaciae [1] and totally resistant TB [2].

Already, we're seeing some pretty scary bugs with CRE (carbapenem-resistant enterobacteriaceae) and XDR-TB (extensively drug-resistant tuberculosis) and others.

They'll kill you if they don't stay in the gut (mine tried, along with a carbapenem-resistant strain of streptococcus introduced via a central line).

Over the past decade, however, carbapenem-resistant Enterobacteriaceae (CRE) have been recognized in health-care settings as a cause of difficult-to-treat infections associated with high mortality.

According to my search: carbapenem-resistant Enterobacterales.

They’re members of a notorious family of multidrug-resistant pathogens, called carbapenem-resistant Enterobacteriaceae (CRE), which collectively have mortality rates as high as 50 percent and have spread rapidly around the globe in recent years.

I have a quick question about "the specific DNA [sites]" in carbapenem-resistant bacteria that "RNA-guided nucleases (RGNs) targets".

Would then this involve regular iterations of new designs of this "RNA-guided" anti-biotics, as newer strands of carbapenem-resistant bacteria evolves and there are new DNA site variations that the anti-biotic needs to target?